January has been a rather quiet month in terms of drug approvals. The month saw 2 drugs pass the regulatory muster and 1 being turned down. Now, let's take a look at some of the biotech stocks awaiting FDA decision in February.
from RTT - Biotech http://ift.tt/2kmLkup
via IFTTT
No comments:
Post a Comment